Related Experiment Videos
Brusatol-induced HL-60 cell differentiation involves NF-kappaB activation.
Muriel Cuendet1, Joell J Gills, John M Pezzuto
1Department of Medicinal Chemistry and Pharmacognosy, College of Pharmacy, University of Illinois at Chicago, Chicago, IL, USA.
Cancer Letters
|March 17, 2004
Summary
Brusatol, a compound from Brucea javanica, triggers leukemia cell differentiation by activating nuclear factor-kappa B (NF-kappaB). This activation is crucial for the differentiation process, offering insights into potential therapeutic mechanisms.
Area of Science:
- Biochemistry
- Molecular Biology
- Cell Biology
Background:
- Brusatol, a quassinoid from Brucea javanica, exhibits anti-leukemic properties by inducing cell differentiation.
- The precise molecular mechanisms underlying brusatol-induced differentiation remain incompletely understood.
Purpose of the Study:
- To elucidate the mechanism of action of brusatol in inducing HL-60 cell differentiation.
- To investigate the role of the Rel/nuclear factor-kappa B (NF-kappaB) signaling pathway in brusatol's effects.
Main Methods:
- HL-60 cells were treated with brusatol and analyzed for gene expression using cDNA macroarrays.
- Electrophoretic mobility shift assays (EMSA) were employed to assess NF-kappaB activation.
- Immunoblotting was used to detect changes in IkappaBalpha levels and phosphorylation.
- The effect of a NF-kappaB translocation inhibitor (SN50) on brusatol-induced differentiation was evaluated.
Main Results:
- Brusatol treatment (25 ng/ml) led to the up-regulation of p100/p52, p105/p50, and p65 mRNA within 8 hours.
- EMSA confirmed NF-kappaB activation, involving the p50 and p65 subunits.
- Immunoblots revealed a decrease in IkappaBalpha and an increase in its phosphorylated form, indicating pathway activation.
- Inhibition of NF-kappaB translocation by SN50 blocked brusatol-induced HL-60 cell differentiation.
Conclusions:
- Brusatol induces the activation and nuclear translocation of NF-kappaB in HL-60 cells.
- NF-kappaB pathway activation is a key mechanism by which brusatol promotes leukemia cell differentiation.
- These findings highlight the therapeutic potential of targeting the NF-kappaB pathway in leukemia treatment.